Long Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) is scheduled to report third quarter earnings Tuesday after the market closes, and the Wall Street Consensus expects revenues (mostly Acthar Gel) … Continue Reading
Read NowLong Ideas - DARA BioSciences (NASDAQ:DARA) released some much-needed positive news Monday morning, reporting the domestic launch of Soltamox, the first oral, liquid formulation of the breast-cancer drug … Continue Reading
Read NowLong Ideas - Canadian-based Nuvo Research (TSE:NRI) announced Monday morning that the FDA has approved its Pliaglis product, a unique local anesthetic designed to minimize pain during aesthetic … Continue Reading
Read NowLong Ideas - Novo Nordisk (NYSE:NVO) already set a new 52-week high this week of $167.74, and shares are poised to again break that high Friday. A European … Continue Reading
Read NowLong Ideas - Huntington’s disease is an inherited neurodegenerative disorder that leads to the progressive degeneration of nerve cells in the brain. The disease is genetic in nature … Continue Reading
Read NowLong Ideas - After being decimated earlier this year on the FDA rejection of Northera, shares of Chelsea Therapeutics (NASDAQ:CHTP) could be rejuvenated as new Phase III results … Continue Reading
Read NowLong Ideas - Deerfield Capital reported a 6.2% stake in InterMune (NASDAQ:ITMN) on Tuesday, causing shares of the biotechnology company to climb 10% in the following trading session. … Continue Reading
Read Now